Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2014 Nov 1.

Published in final edited form as: Biomaterials. 2013 Aug 19;34(35):8909–8917. doi: 10.1016/j.biomaterials.2013.07.099

Fig. 1 — Selection and characterization of CD30-binding aptamers. A) Resulting individual aptamer sequences from the sequencing of pools of aptamers that demonstrating high affinity for target cells. B) Aptamers tested against CD30-positive and CD30-negative cells. C) Binding curves of aptamers (or apparent Kds) against CD30-positive and CD30-negative cells.

Fig. 1 — Selection and characterization of CD30-binding aptamers. A) Resulting individual aptamer sequences from the sequencing of pools of aptamers that demonstrating high affinity for target cells. B) Aptamers tested against CD30-positive and CD30-negative cells. C) Binding curves of aptamers (or apparent Kds) against CD30-positive and CD30-negative cells.